Ovid Therapeutics (OVID) EBIT (2016 - 2026)
Ovid Therapeutics' EBIT came in at -$15.7 million for Q2 2026, compared with -$5.07 million a year earlier.
Powered by 
Analysis
Ovid Therapeutics (OVID) EBIT (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ovid Therapeutics reported EBIT of -$58.36 million; for FY2025, it came in at -$42.44 million.
- Going back by year, EBIT was -$61.89 million in FY2024, -$59.28 million in FY2023, -$55.55 million in FY2022 and $124.21 million in FY2021.
- The five-year range for quarterly EBIT is -$26.35 million (Q4 2021) to -$5.07 million (Q2 2025).
- Business Quant data shows OVID's EBIT at -$17.85 million (Q1 2026), -$12.29 million (Q4 2025) and -$12.52 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Ovid Therapeutics | 517.72 Mn | 149.74 Mn | - | -15.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.70 Mn |
| Mar 31, 2026 | -17.85 Mn |
| Dec 31, 2025 | -12.29 Mn |
| Sep 30, 2025 | -12.52 Mn |
| Jun 30, 2025 | -5.07 Mn |
| Mar 31, 2025 | -12.55 Mn |
| Dec 31, 2024 | -10.72 Mn |
| Sep 30, 2024 | -13.23 Mn |
| Jun 30, 2024 | -20.52 Mn |
| Mar 31, 2024 | -17.42 Mn |
| Dec 31, 2023 | -18.19 Mn |
| Sep 30, 2023 | -12.03 Mn |
| Jun 30, 2023 | -14.17 Mn |
| Mar 31, 2023 | -14.89 Mn |
| Dec 31, 2022 | -12.17 Mn |
| Sep 30, 2022 | -12.80 Mn |
| Jun 30, 2022 | -14.30 Mn |
| Mar 31, 2022 | -16.27 Mn |
| Dec 31, 2021 | -26.35 Mn |
| Sep 30, 2021 | -11.68 Mn |
API Access
Ovid Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();